Summary
Global pediatric VAD programs outside North America have not been well described, even as ventricular assist devices have become established therapy for children with end-stage heart failure.
Through ACTION, researchers sent a 12-question survey to 74 healthcare professionals at pediatric VAD programs outside North America. Fifteen responses came back, representing 15 centers across 14 countries, 13 of which had established programs. Most reported managing between one and five pediatric VAD patients a year.
The Berlin Heart EXCOR and HeartMate 3 were available at 11 of 13 centers, but fewer than half had a dedicated VAD coordinator. The most commonly cited barrier was inadequate education for intensive care and nursing staff and for patients, reported by 9 of 13 centers, followed by financial constraints and limited device availability. Four of the 13 centers had never discharged a patient home on VAD support.
The authors conclude that device availability, team resources, and program experience vary substantially by region, and point to international collaboration as a way to close those gaps.
This ACTION study was published online ahead of print in ASAIO Journal on November 5, 2026. Congratulations to the authors:
- Ah Young Kim
- Alfred Asante-Korang
- HaEun Jazmin Kim
- Angela Lorts
- Robert A. Niebler
- Matthew J. O’Connor
- Nikita Orwick
- David Rosenthal
- Swati Sehgal
- David Sutcliffe
- Christina VanderPluym
- Matthew Zinn
- Anna Joong
CITATION
Kim AY, Asante-Korang A, Kim HJ, et al. Current global trends and challenges of pediatric ventricular assist device programs: an ACTION collaborative survey. ASAIO J. Published online November 5, 2026. doi:10.1097/MAT.0000000000002909
